IVERIC bio Inc

NASDAQ:ISEE   1:00:00 PM EDT
21.56
-0.18 (-0.83%)
: $21.12 -0.44 (-2.04%)
Products

Iveric Bio Announces FDA Has Granted Therapy Designation For Avacincaptad Pegol

Published: 11/17/2022 22:28 GMT
IVERIC bio Inc (ISEE) - Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy.
Iveric Bio Inc - Company is on Track to Complete Final Part of NDA Submission by End of This Year.